Bristol-Myers Squibb Company BMY · SEC Filings

website

32.5K

Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the...

Price62.14

Market Cap127.02 B

Float2.04 B

CountryUS

SectorHealthcare

ExchangeNYSE

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 8, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Nov 10, 2025

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Nov 5, 2025

POSASR

Form POSASR - Post-effective Amendment to an automatic shelf registration statement

Oct 31, 2025

SC TO-T/A

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

May 13, 2025

SC TO-T/A

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

May 6, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Haller Julia A (Reporting)

Nov 6, 2026

144

Form 144 - Report of proposed sale of securities

Nov 6, 2026

Lenkowsky Adam (Reporting)

Nov 4, 2026

BOERNER CHRISTOPHER S. (Reporting)

Nov 3, 2026

Shanahan Karin (Reporting)

Nov 3, 2026

Meyers Gregory Scott (Reporting)

Nov 3, 2026

Other

TYPE

HEADLINE

FILED AT

CORRESP

Form CORRESP - Correspondence

Feb 16, 2024

LETTER

Form UPLOAD - SEC-generated letter

Apr 8, 2022

CORRESP

Form CORRESP - Correspondence

Apr 6, 2022

CORRESP

Form CORRESP - Correspondence

Jan 18, 2022

LETTER

Form UPLOAD - SEC-generated letter

Dec 16, 2021

LETTER

Form UPLOAD - SEC-generated letter

Feb 1, 2021